The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
New developments in Plasmodium vivax malaria: severe disease and the rise of chloroquine resistance
Abstract
PURPOSE OF REVIEW: Unlike Plasmodium falciparum, Plasmodium vivax rarely causes severe disease in healthy travellers or in temperate endemic regions and has been regarded as readily treatable with chloroquine. However, in tropical areas, recent reports have highlighted severe and fatal disease associated with P. vivax infection. We review the evidence for severe disease and the spread of drug-resistant P. vivax and speculate how these maybe related. RECENT FINDINGS: Studies from Indonesia, Papua New Guinea, Thailand and India have shown that 21-27% of patients with severe malaria have P. vivax monoinfection. The clinical spectrum of these cases is broad with an overall mortality of 0.8-1.6%. Major manifestations include severe anaemia and respiratory distress, with infants being particularly vulnerable. Most reports of severe and fatal vivax malaria come from endemic regions where populations have limited access to healthcare, a high prevalence of comorbidity and where drug-resistant P. vivax strains and partially effective primaquine regimens significantly undermine the radical cure and control of this relapsing infection. The mechanisms underlying severe disease in vivax malaria remain poorly defined. SUMMARY: Severe, fatal and multidrug-resistant vivax malaria challenge our perception of P. vivax as a benign disease. Strategies to understand and address these phenomena are needed urgently if the global elimination of malaria is to succeed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The global distribution and population at risk of malaria: past, present, and future
Hay, S. I., Guerra, C. A., Tatem, A. J., Noor, A. M., & Snow, R. W. (2004) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(04)01043-6 · Cited by 1,001
The neglected burden of Plasmodium vivax malaria
Mendis, K., Sina, B., Marchesini, P., & Carter, R. (2001) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2001.64.97 · Cited by 970
Vivax Malaria: Neglected and Not Benign
Price, R. N., Tjitra, E., Guerra, C. A., Yeung, S., White, N. J., & Anstey, N. M. (2007) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2007.77.79 · Cited by 838
Self-citationTjitra, E., Anstey, N. M., Sugiarto, P., Warikar, N., Kenangalem, E., Karyana, M., Lampah, D. A., & Price, R. N. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050128 · Cited by 611
Self-citationPLASMODIUM VIVAX RESISTANCE TO CHLOROQUINE?
Rieckmann, K. H., Davis, D. R., & Hutton, D. C. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91792-3 · Cited by 501
Nosten, F., van Vugt, M., Price, R., Luxemburger, C., Thway, K., Brockman, A., McGready, R., ter Kuile, F., Looareesuwan, S., & White, N. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02505-8 · Cited by 500
Self-citationAntimalarial drug resistance and combination chemotherapy
White, N. (1999) · Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rstb.1999.0426 · Cited by 477
Genton, B., D'Acremont, V., Rare, L., Baea, K., Reeder, J. C., Alpers, M. P., & Müller, I. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050127 · Cited by 463
The pathophysiology of vivax malaria
Anstey, N. M., Russell, B., Yeo, T. W., & Price, R. N. (2009) · Trends in Parasitology · doi:10.1016/j.pt.2009.02.003 · Cited by 428
Self-citationSevere Plasmodium vivax Malaria: A Report on Serial Cases from Bikaner in Northwestern India
Kochar, D. K., Das, A., Kochar, S. K., Saxena, V., Sirohi, P., Garg, S., Kochar, A., Khatri, M. P., & Gupta, V. (2009) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2009.80.194 · Cited by 398
Kochar, D. K., Saxena, V., Singh, N., Kochar, S. K., Kumar, S. V., & Das, A. (2005) · Emerging Infectious Diseases · doi:10.3201/eid1101.040519 · Cited by 382
Effects of Plasmodium vivax malaria in pregnancy.
Nosten, F., McGready, R., Simpson, J., Thwai, K., Balkan, S., Cho, T., Hkirijaroen, L., Looareesuwan, S., & White, N. (1999) · The Lancet · doi:10.1016/s0140-6736(98)09247-2 · Cited by 381
Ratcliff, A., Siswantoro, H., Kenangalem, E., Maristela, R., Wuwung, R., Laihad, F., Ebsworth, E., Anstey, N., Tjitra, E., & Price, R. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60160-3 · Cited by 271
Self-citationNeglect of Plasmodium vivax malaria
Baird, J. K. (2007) · Trends in Parasitology · doi:10.1016/j.pt.2007.08.011 · Cited by 266
Suwanarusk, R., Russell, B., Chavchich, M., Chalfein, F., Kenangalem, E., Kosaisavee, V., Prasetyorini, B., Piera, K. A., Barends, M., Brockman, A., et al. (2007) · PLoS ONE · doi:10.1371/journal.pone.0001089 · Cited by 247
Self-citationKorenromp, E. L., Williams, B. G., Gouws, E., Dye, C., & Snow, R. W. (2003) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(03)00657-1 · Cited by 245
Resistance to Chloroquine by Plasmodium vivax in Irian Jaya, Indonesia
Baird, J. K., Basri, H., Purnomo, Bangs, M. J., Subianto, B., Patchen, L. C., & Hoffman, S. L. (1991) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1991.44.547 · Cited by 232
Vivax malaria resistant to treatment and prophylaxis with chloroquine
Murphy, G. S., Basri, H., Andersen, E. M., Bangs, M. J., Gorden, J., Sorensen, K., Mount, D. L., Lal, A. A., Purwokusumo, A. R., Harjosuwarno, S., et al. (1993) · The Lancet · doi:10.1016/0140-6736(93)92568-e · Cited by 209
Anstey, N. M., Handojo, T., Pain, M. C. F., Kenangalem, E., Tjitra, E., Price, R. N., & Maguire, G. P. (2007) · The Journal of Infectious Diseases · doi:10.1086/510756 · Cited by 202
Self-citationA Trial of Combination Antimalarial Therapies in Children from Papua New Guinea
Karunajeewa, H. A., Mueller, I., Senn, M., Lin, E., Law, I., Gomorrai, P. S., Oa, O., Griffin, S., Kotab, K., Suano, P., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0804915 · Cited by 197
Barcus, M. J., Basri, H., Picarima, H., Manyakori, C., Sekartuti, Elyazar, I., Bangs, M. J., Maguire, J. D., & Baird, J. K. (2007) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2007.77.984 · Cited by 196
Parasite Multiplication Potential and the Severity of Falciparum Malaria
Chotivanich, K., Udomsangpetch, R., Simpson, J. A., Newton, P., Pukrittayakamee, S., Looareesuwan, S., & White, N. J. (2000) · The Journal of Infectious Diseases · doi:10.1086/315353 · Cited by 191
Ratcliff, A., Siswantoro, H., Kenangalem, E., Wuwung, M., Brockman, A., Edstein, M. D., Laihad, F., Ebsworth, E. P., Anstey, N. M., Tjitra, E., et al. (2007) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/j.trstmh.2006.06.008 · Cited by 172
Self-citationVivax Malaria: A Major Cause of Morbidity in Early Infancy
Poespoprodjo, J. R., Fobia, W., Kenangalem, E., Lampah, D. A., Hasanuddin, A., Warikar, N., Sugiarto, P., Tjitra, E., Anstey, N. M., & Price, R. N. (2009) · Clinical Infectious Diseases · doi:10.1086/599041 · Cited by 164
Self-citationHasugian, A. R., Purba, H., Kenangalem, E., Wuwung, R. M., Ebsworth, E. P., Maristela, R., Penttinen, P. M., Laihad, F., Anstey, N. M., Tjitra, E., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/512677 · Cited by 151
Self-citationAnstey, N. M., Jacups, S. P., Cain, T. M., Pearson, T., Ziesing, P., Fisher, D. A., Currie, B. J., Marks, P. J., & Maguire, G. P. (2002) · The Journal of Infectious Diseases · doi:10.1086/339885 · Cited by 149
Self-citationPoespoprodjo, J. R., Fobia, W., Kenangalem, E., Lampah, D. A., Warikar, N., Seal, A., McGready, R., Sugiarto, P., Tjitra, E., Anstey, N. M., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/586743 · Cited by 148
Self-citationCarrara, V. I., Sirilak, S., Thonglairuam, J., Rojanawatsirivet, C., Proux, S., Gilbos, V., Brockman, A., Ashley, E. A., McGready, R., Krudsood, S., et al. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030183 · Cited by 146
Chloroquine-ResistantPlasmodiumvivax, Brazilian Amazon
Filho, F. S. D. S., Arcanjo, A. R. L., Chehuan, Y. M., Costa, M. R. F., Martínez-Espinosa, F. E., Vieira, J. L. F., Barbosa, M. D. G. V., Alecrim, W. D., & Alecrim, M. D. G. C. (2007) · Emerging infectious diseases · doi:10.3201/eid1307.061386 · Cited by 146
Cerebral involvement in benign tertian malaria.
Beg, M. A., Khan, R., Baig, S. M., Gulzar, Z. G., Hussain, R., & Ra, S. (2002) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2002.67.230 · Cited by 146
Determinants of In Vitro Drug Susceptibility Testing of Plasmodium vivax
Russell, B., Chalfein, F., Prasetyorini, B., Kenangalem, E., Piera, K. A., Suwanarusk, R., Brockman, A., Prayoga, P., Sugiarto, P., Cheng, Q., et al. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01334-07 · Cited by 139
Self-citationAmplification ofpvmdr1Associated with Multidrug‐ResistantPlasmodium vivax
Suwanarusk, R., Chavchich, M., Russell, B., Jaidee, A., Chalfein, F., Barends, M., Prasetyorini, B., Kenangalem, E., Piera, K. A., Lek‐Uthai, U., et al. (2008) · The Journal of Infectious Diseases · doi:10.1086/592451 · Cited by 137
Self-citationTjitra, E., Baker, J., Suprianto, S., et al. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.12.3947-3953.2002 · Cited by 128
Barnadas, C., Ratsimbasoa, A. C., Tichit, M., Bouchier, C., Jahevitra, M., Picot, S., & Ménard, D. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00578-08 · Cited by 127
High Deformability ofPlasmodium vivax–Infected Red Blood Cells under Microfluidic Conditions
Handayani, S., Chiu, D. T., Tjitra, E., Kuo, J. S., Lampah, D. A., Kenangalem, E., Rénia, L., Snounou, G., Price, R. N., Anstey, N. M., et al. (2008) · The Journal of Infectious Diseases · doi:10.1086/596048 · Cited by 124
Self-citationSumawinata, I. W., BERNADETA, Leksana, B., Sutamihardja, A., Purnomo, P., Subianto, B., Sekartuti, Fryauff, D. J., & Baird, J. K. (2003) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2003.68.416 · Cited by 121
Treatment of Chloroquine-Resistant Plasmodium vivax with Chloroquine and Primaquine or Halofantrine
Baird, J. K., Basri, H., Subianto, B., et al. (1995) · The Journal of Infectious Diseases · doi:10.1093/infdis/171.6.1678 · Cited by 115
Retention of erythrocytes in the spleen: a double-edged process in human malaria
Buffet, P. A., Safeukui, I., Milon, G., Mercereau‐Puijalon, O., & David, P. H. (2009) · Current Opinion in Hematology · doi:10.1097/moh.0b013e32832a1d4b · Cited by 115
Defining Childhood Severe Falciparum Malaria for Intervention Studies
Bejon, P., Berkley, J. A., Mwangi, T., Ogada, E. A., Mwangi, I., Maitland, K., Williams, T. N., Scott, J. A. G., English, M., Lowe, B. S., et al. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040251 · Cited by 112
Russell, B., Udomsangpetch, R., Rieckmann, K. H., Kotecka, B. M., Coleman, R. E., & Sattabongkot, J. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.1.170-173.2003 · Cited by 106
Acute lung injury and other serious complications of Plasmodium vivax malaria
Tan, L., Yacoub, S., Scott, S., Bhagani, S., & Jacobs, M. (2008) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(08)70153-1 · Cited by 106
Chloroquine-resistant Plasmodium vivax malaria in Debre Zeit, Ethiopia
Teka, H., Petros, B., Yamuah, L. K., Tesfaye, G., Elhassan, I. M., Muchohi, S. N., Kokwaro, G. O., Aseffa, A., & Engers, H. D. (2008) · Malaria Journal · doi:10.1186/1475-2875-7-220 · Cited by 102
Price, R. N., Hasugian, A. R., Ratcliff, A., Siswantoro, H., Purba, H., Kenangalem, E., Lindegårdh, N., Penttinen, P. M., Laihad, F., Ebsworth, E. P., et al. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00486-07 · Cited by 97
Self-citationSurvey of resistance to chloroquine by Plasmodium vivax in Indonesia
Baird, J. K., Nalim, M. F. S., Basri, H., Masbar, S., Leksana, B., Tjitra, E., Dewi, R. M., Khairani, M., & Wignall, F. S. (1996) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/s0035-9203(96)90526-x · Cited by 96
High-dose Primaquine Regimens against Relapse of Plasmodium vivax Malaria
Krudsood, S., Tangpukdee, N., Wilairatana, P., Phophak, N., Baird, J. K., Brittenham, G. M., & Looareesuwan, S. (2008) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2008.78.736 · Cited by 94
Sá, J. M., Nomura, T., Neves, J. D., Baird, J. K., Wellems, T. E., & Portillo, H. A. D. (2005) · Experimental Parasitology · doi:10.1016/j.exppara.2004.12.005 · Cited by 93
Plasmodium vivax resistance to chloroquine in Dawei, southern Myanmar
Guthmann, J., Pittet, A., Lesage, A., Imwong, M., Lindegårdh, N., Lwin, M. M., Zaw, T., Annerberg, A., de Radiguès, X., & Nosten, F. H. (2008) · Tropical Medicine & International Health · doi:10.1111/j.1365-3156.2007.01978.x · Cited by 77
A systematic overview of published antimalarial drug trials
Myint, H. Y., Tipmanee, P., Nosten, F. H., Day, N., Pukrittayakamee, S., Looareesuwan, S., & White, N. J. (2003) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/s0035-9203(03)00014-2 · Cited by 76
Plasmodium vivax trophozoites insensitive to chloroquine
Sharrock, W. W., Suwanarusk, R., Lek‐Uthai, U., Edstein, M. D., Kosaisavee, V., Travers, T., Jaidee, A., Sriprawat, K., Price, R. N., Nosten, F. H., et al. (2008) · Malaria Journal · doi:10.1186/1475-2875-7-94 · Cited by 64
Self-citationPlasmodium vivax and the importance of the subtelomeric multigene vir superfamily
Fernández-Becerra, C., Yamamoto, M. M., Vêncio, R. Z. N., Lacerda, M., Rosanas‐Urgell, A., & Portillo, H. A. D. (2008) · Trends in Parasitology · doi:10.1016/j.pt.2008.09.012 · Cited by 62
Emergence of chloroquine-resistant vivax malaria in south Bihar (India)
Singh, R. K. (2000) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/s0035-9203(00)90344-4 · Cited by 53
Valecha, N., Joshi, H., Eapen, A. K., Ravinderan, J., Kumar, A., Prajapati, S. K., & Ringwald, P. (2006) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/j.trstmh.2005.11.012 · Cited by 49
IN VITRO EFFICACY OF ANTIMALARIAL DRUGS AGAINST PLASMODIUM VIVAX ON THE WESTERN BORDER OF THAILAND
Chotivanich, K., Udomsangpetch, R., Chierakul, W., Newton, P. N., Ruangveerayuth, R., Pukrittayakamee, S., Looareesuwan, S., & White, N. J. (2004) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2004.70.395 · Cited by 49
Chloroquine-resistant Plasmodium vivax in the Republic of Korea
Lee, K. S., Kim, T. H., Kim, E. S., Lim, H., Yeom, J., Jun, G., & Park, J.-W. (2009) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2009.80.215 · Cited by 47
Zakeri, S., Rabiee, S., Afsharpad, M., & Djadid, N. D. (2009) · Malaria Journal · doi:10.1186/1475-2875-8-20 · Cited by 42
Clinical Features of Plasmodium Vivax Malaria
Song, H. H., Soon Ok, O., Kim, S. H., Moon, S. H., Kim, J. B., Yoon, J., Koo, J.-R., Hong, K. S., Lee, M. G., Kim, D. J., et al. (2003) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2003.18.4.220 · Cited by 39
Kolaczinski, K., Durrani, N., Rahim, S., & Rowland, M. (2007) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/j.trstmh.2007.06.015 · Cited by 39
Lek‐Uthai, U., Suwanarusk, R., Ruengweerayut, R., Skinner‐Adams, T. S., Nosten, F. H., Gardiner, D. L., Boonma, P., Piera, K. A., Andrews, K. T., MacHunter, B., et al. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00169-08 · Cited by 36
Self-citationFryauff, D. J., Leksana, B., Masbar, S., Wiady, I., Sismadi, P., Susanti, A. I., Nagesha, H. S., Syafruddin, Atmosoedjono, S., Bangs, M. J., et al. (2002) · Annals of Tropical Medicine and Parasitology · doi:10.1179/000349802125001249 · Cited by 32
Is Anemia in Plasmodium vivax Malaria More Frequent and Severe than in Plasmodium falciparum?
Rodriguez-Morales, A. J., Sánchez, E., Vargas, M., Piccolo, C., Colina, R., Arria, M., & Franco‐Paredes, C. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.08.014 · Cited by 29
Tasanor, O., Ruengweerayut, R., Sirichaisinthop, J., Congpuong, K., Wernsdorfer, W. H., & Na‐Bangchang, K. (2006) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/j.trstmh.2005.04.024 · Cited by 28
Antimalarial Drug Susceptibility of Plasmodium vivax in the Republic of Korea
Chotivanich, K., Sattabongkot, J., Choi, Y. K., Park, J. S., Sritabal, J., Lim, C. S., Udomsangpetch, R., White, N. J., & Lee, W. J. (2009) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2009.80.902 · Cited by 15
Clinical efficacy of chloroquine followed by primaquine for Plasmodium vivax treatment in Azerbaijan
Valibayov, A., Abdullayev, F., Mammadov, S., et al. (2003) · Acta Tropica · doi:10.1016/s0001-706x(03)00188-8 · Cited by 13
Singh, J., Shakya, N., Jain, D. C., Bhatia, R., Bora, D., Pattanayak, P., Gupta, S., Datta, K. K., & Sokhey, J. (2000) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/s0035-9203(00)90305-5 · Cited by 6
Cited by
(2014) · Tropical Medicine & International Health · doi:10.1111/tmi.12313_2 · Cited by 543
A Long Neglected World Malaria Map: Plasmodium vivax Endemicity in 2010
Gething, P. W., Elyazar, I. R. F., Moyes, C. L., Smith, D. L., Battle, K. E., Guerra, C. A., Patil, A. P., Tatem, A. J., Howes, R. E., Myers, M. F., et al. (2012) · PLoS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0001814 · Cited by 538
Self-citationGlobal Epidemiology of Plasmodium vivax
Howes, R. E., Battle, K. E., Mendis, K. N., Smith, D. L., Cibulskis, R. E., Baird, J. K., & Hay, S. I. (2016) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.16-0141 · Cited by 418
Evidence and Implications of Mortality Associated with Acute Plasmodium vivax Malaria
Baird, J. K. (2013) · Clinical Microbiology Reviews · doi:10.1128/cmr.00074-12 · Cited by 398
“The uncertainties regarding causation versus association from patient settings have been explained carefully in the context of severe illness and vivax malaria (140, 141).”
BackgroundGlobal extent of chloroquine-resistant Plasmodium vivax: a systematic review and meta-analysis
Price, R. N., von Seidlein, L., Valecha, N., Nosten, F., Baird, J. K., & White, N. J. (2014) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(14)70855-2 · Cited by 388
Self-citation
Metadata
- Authors
- Price, R. N., Douglas, N. M., & Anstey, N. M.
- Venue
- Current Opinion in Infectious Diseases
- Published
- 2009-10
- Volume
- 22
- Issue
- 5
- Pages
- 430-435
- ISSN
- 0951-7375 (ISSN-L)
- OpenAlex
- W2010274630
- Cited by
- 343
- References
- 64
- FWCI
- 31.49
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.